Blog
RSS FeedPosted by Michael Wonder on 18 Mar 2019
Reimbursement for orphan drug Spinraza imminent
18 March 2019 - Biogen’s Spinraza (nusinersen), a treatment for spinal muscular atrophy, is likely to obtain reimbursement as early ...
Posted by Michael Wonder on 27 Feb 2019
Korea’s 30th novel drug K-Cab to get insurance benefit from March
27 February 2019 - Korea’s 30th novel medicine K-Cab Tab. (tegoprazan) will receive insurance coverage, eight months after winning approval, the ...
Posted by Michael Wonder on 26 Feb 2019
Lung cancer second treatment Alunbrig likely to get insurance coverage
25 February 2019 - The National Health Insurance Service’s drug price assessment committee recently evaluated Takeda’s Alunbrig (briganitib) as eligible ...